Tag: scientists

Study Reveals How Small Changes in Walking Technique May Help Treat Knee Osteoarthritis

NEW YORK, Aug. 12, 2025 /PRNewswire/ -- Gait analysis and pain measures show that subtly adjusting the angle of the foot during walking may...

Fighting Game GOAT Justin Wong Joins BASILISK, Science’s Esports Team

Nine-time Evo Champion and Guinness World Record Holder Brings Legendary Status to Captain New Team, Recruit Talent, and Advance Science's Role in Competitive Gaming...

5 Pew-Stewart Scholars Selected to Pursue Pioneering Cancer Research

PHILADELPHIA, Aug. 12, 2025 /PRNewswire/ -- The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced today the 2025 class of the...

Alaska is one step closer to improved broadband with completion of FISH submarine cable marine route surveys

Pioneer Consulting is pleased to announce the completion of the marine route surveys for the “Fiber Internet Serving Homes” projects.

izmo Ltd. unveils The Automotive AI Factory

Powering the Future of Intelligent Automotive Solutions BANGALORE, India, Aug. 12, 2025 /PRNewswire/ -- izmo Ltd., a global leader in automotive digital retail solutions, today announced...

Boehringer Ingelheim Celebrates Next Generation of Biomedical Researchers at 2025 Veterinary Scholars Symposium

Student researchers from Mississippi State University and The Ohio State University received Boehringer Ingelheim research awards DULUTH, Ga., Aug. 11, 2025 /PRNewswire/ -- Veterinary research took...

REPEAT — Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion...

WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today announced its top-line revenue forecast for its specialty care pipeline, projecting nearly $1 billion in revenue in its launch year and a cumulative 5-year estimate of between $18 billion and $22 billion. This forecast reflects the company’s unique, faster, and cost-efficient drug development model which has the potential to serve as a blueprint to ensure sustainable medical innovation for years to come.

Narwal Launches the S20 to Revolutionize Smart Home Technology With All-in-One Cordless Vacuum Mop Cleaner

KUALA LUMPUR, Malaysia, Aug. 11, 2025 /PRNewswire/ -- Narwal, the international leader in smart home cleaning, is proud to announce its latest innovative home cleaning...

Public and Private Sectors Unite to Enhance Vision Care Access for Patients in Need Ahead of SG60

SNEC, Spectacle Hut, and the OneSight EssilorLuxottica Foundation streamline access to specialised eyewear for low vision patients ahead of SG60.

KLA Declares Regular Cash Dividend

MILPITAS, Calif., Aug. 7, 2025 /PRNewswire/ -- The KLA Corporation (NASDAQ: KLAC) Board of Directors today declared a quarterly cash dividend of $1.90 per...

ALMORA BOTANICA GRANTED TWO GROUNDBREAKING PATENTS

A New Era of Ayurvedic Skincare Innovation LONDON, Aug. 7, 2025 /PRNewswire/ -- Almora Botanica, the pioneering science-first Ayurvedic skincare brand, has secured two groundbreaking...

Lilly reports second-quarter 2025 financial results and raises guidance

Revenue in Q2 2025 increased 38% to $15.56 billion driven by volume growth from Zepbound and Mounjaro. Increased the midpoint of our 2025 full-year...

Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results

Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the third quarter of 2025 Initiated ALKAZAR...

Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma

Modeyso is the first treatment option for this ultra-rare and aggressive brain tumor, which primarily affects children and young adults Accelerated approval based on an...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsScientists

CST Tires Showcases Lightweight Innovation at 2026 China International Bicycle Expo

PICS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PicS N.V. and Announces Opportunity for Investors with Substantial Losses...

JEF INVESTIGATION: Robbins Geller Rudman & Dowd LLP Launches Investigation into Jefferies Financial Group, Inc. and Encourages Investors and Potential Witnesses to Contact Law...